These variants were exclusively identified in HCAR1 and HCAR3, which is notable considering their suggested oncogenic role and requirement for BC proliferation/survival compared to the demonstrated tumor suppressor properties of HCAR2 [4–6]. The gene discussed is HCAR2; the disease is neoplasm.